Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

Triple-negative breast cancer (TNBC) is a heterogeneous disease in which the tumors do not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor 2 (HER2). Classical receptor-targeted therapies such as tamoxifen or trastuzumab are therefore unsuitable a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncotarget
मुख्य लेखकों: Amoury, Manal, Bauerschlag, Dirk, Zeppernick, Felix, von Felbert, Verena, Berges, Nina, Di Fiore, Stefano, Mintert, Isabell, Bleilevens, Andreas, Maass, Nicolai, Bräutigam, Karen, Meinhold-Heerlein, Ivo, Stickeler, Elmar, Barth, Stefan, Fischer, Rainer, Hussain, Ahmad Fawzi
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Impact Journals LLC 2016
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342391/
https://ncbi.nlm.nih.gov/pubmed/27448975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10705
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन